CollPlant Biotechnologies
(NASDAQ) CLGN
CollPlant Biotechnologies Financials at a Glance
Market Cap
$5.69M
Revenue (TTM)
$389.00K
Net Income (TTM)
-$13.13M
EPS (TTM)
-$1.03
P/E Ratio
-0.38
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$0.38
Volume
1,421
Open
$0.39
Price
$0.38
Volume
1,421
Open
$0.39
Previous Close
$0.38
Daily Range
$0.38 - $0.39
52-Week Range
$0.27 - $3.23
Estimated Earnings Date
Aug 19, 2026
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$0.38
Volume
1,421
Open
$0.39
Previous Close
$0.38
Daily Range
$0.38 - $0.39
52-Week Range
$0.27 - $3.23
Estimated Earnings Date
Aug 19, 2026
CLGN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CollPlant Biotechnologies
Industry
Biotechnology
Sector
Health CareEmployees
39
CEO
Yehiel Tal
Website
www.collplant.comHeadquarters
Rehovot, 7670104, IL
CLGN Financials
Key Financial Metrics (TTM)
Gross Margin
-3%
Operating Margin
-33%
Net Income Margin
-34%
Return on Equity
-152%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-2.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.69M
Shares Outstanding
14.42M
Volume
1.42K
Avg. Volume
80.85K
Financials (TTM)
Gross Profit
$624.00K
Operating Income
-$11.48M
EBITDA
-$10.57M
Operating Cash Flow
-$9.42M
Capital Expenditure
-$28.00K
Free Cash Flow
-$9.45M
Cash & ST Invst.
$5.95M
Total Debt
$2.85M
CollPlant Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$73.00K
-96.4%
Gross Profit
-$243.00K
-115.0%
Gross Margin
-3.33%
N/A
Market Cap
$5.69M
N/A
Market Cap/Employee
$99.87K
N/A
Employees
57
N/A
Net Income
-$3.10M
-113.3%
EBITDA
-$2.91M
-140.5%
Quarterly Fundamentals
Net Cash
$1.61M
-79.6%
Accounts Receivable
$233.00K
-47.0%
Inventory
$679.00K
+0.9%
Long Term Debt
$1.86M
-12.1%
Short Term Debt
$794.00K
+8.5%
Return on Assets
-1.43%
N/A
Return on Invested Capital
-1.92%
N/A
Free Cash Flow
-$3.06M
-159.8%
Operating Cash Flow
-$3.05M
-161.3%